NCT05910476Active, not recruitingPhase 4
Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)
A Randomized comparaTive Study Of Rosuvastatin/Ezetimibe 20/10mg and Atorvastatin/Ezetimibe 40/10mg in Patients With Coronary Artery Drug eLuting stEnt Implantation Requiring High-dose stAtin/Ezetimibe combiNaTion Therapy: TOLERANT Trial
Source: ClinicalTrials.gov · Last updated 25 Nov 2025
Brief summary (registry, in English)
the investigators would like to compare the differences between roschvastin and atovastatin in patients who require high-dose statin/ejetimib to undergo a new generation of drug elution stent implantation for cardiovascular disease and maintain LDL cholesterol below 55 mg/dL.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 31 Mar 2023
- Start date
- 3 May 2023
- Primary completion date
- 22 Sept 2026
- Lead sponsor
- Yonsei University
- Diseases
- Coronary artery disease
- NCT number
- NCT05910476
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 200
- From 3 May 2023 to the primary completion date, 22 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Allergies or overreactions to statins
Lab values
- LDL cholesterol levels below 55 mg/dL without statin treatment
- Serum AST/ALT with an acute liver disease within a month or a normal upper limit that is not continuously explained
Other
- Estimated Dawn of Less than 1 Year
- If it is determined that follow-up is not possible for more than one year
- Pregnancy
Who the study is looking for
- 19 years of age or older
- Patients who underwent a new generation of drug elution stent implantation for cardiovascular disease
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yongin Severance Hospital Coordinator of this site? Confirm its status | Yŏngin | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.